JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB136812

Apoptosis Western Blot Cocktail (pro/p17-caspase-3, cleaved PARP1, muscle actin)

Be the first to review this product! Submit a review

|

(51 Publications)

Apoptosis Western Blot Cocktail (pro/cleaved Caspase-3, cleaved PARP1, Muscle Actin) (ab136812). For detection of the apoptosis biomarkers Caspase 3 and cleaved PARP, along with the loading control muscle actin.

- Cited in over 30 publications

View Alternative Names

CPP32, CASP3, Caspase-3, CASP-3, Apopain, Cysteine protease CPP32, Protein Yama, SREBP cleavage activity 1, CPP-32, SCA-1, ACTC, ACTC1, Alpha-cardiac actin, ADPRT, PPOL, PARP1, Poly [ADP-ribose] polymerase 1, PARP-1, ADP-ribosyltransferase diphtheria toxin-like 1, DNA ADP-ribosyltransferase PARP1, NAD(+) ADP-ribosyltransferase 1, Poly[ADP-ribose] synthase 1, Protein poly-ADP-ribosyltransferase PARP1, ARTD1, ADPRT 1

2 Images
Western blot - Apoptosis Western Blot Cocktail (pro/p17-caspase-3, cleaved PARP1, muscle actin) (AB136812)
  • WB

Supplier Data

Western blot - Apoptosis Western Blot Cocktail (pro/p17-caspase-3, cleaved PARP1, muscle actin) (AB136812)

Lanes 1, 3, 5, 7 : (ab136806) HeLa, vehicle treated
Lanes 2, 4, 6, 8 : (ab136806) HeLa, 1 µM staurosporine (ab120056), 4 hours
All lysates at 20 µg per lane.

Primary antibodies

Lanes 1, 2 : Cleaved PARP
Lanes 3, 4 : Actin
Lanes 5, 6 : Caspase 3
Lanes 7, 8 : ab136812 250X Primary Antibodies Cocktail, 1/250 dilution

Secondary antibodies

All lanes : ab136812 100X HRP-Conjugated Secondary Antibodies Cocktail, 1/100 dilution.

false

Western blot - Apoptosis Western Blot Cocktail (pro/p17-caspase-3, cleaved PARP1, muscle actin) (AB136812)
  • WB

Supplier Data

Western blot - Apoptosis Western Blot Cocktail (pro/p17-caspase-3, cleaved PARP1, muscle actin) (AB136812)

Lane 1 : Jurkat cells, untreated
Lane 2 : Jurkat cells treated with anti-FAS for 2 hours
Lane 3 : Jurkat cells treated with anti-FAS for 4 hours
Lane 4 : Jurkat cells treated with anti-FAS for 6 hours

All lysates at 20 μg/lane

Primary antibodies

All lanes : 250X Primary Antibodies Cocktail, 1/250 dilution.

Secondary antibodies

All lanes : 100X HRP-Conjugated Secondary Antibodies Cocktail (ab136812), 1/100 dilution.

false

Key facts

Applications

WB

applications

Target

CASP3

target

Reacts with

Human

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>1/250 dilution for primary antibodies. 1/100 dilution for secondary antibodies. Suggested dilution buffer: 5% milk/PBS+0.05% Tween 20.</p>" } } }

Product details

ab136812 contains a cocktail of primary antibodies for the detection of apoptosis biomarkers caspase 3 and PARP, along with loading control muscle actin (42 kDa). The caspase 3 antibody (rabbit monoclonal) detects both the 32 kDa pro-caspase 3 as well as the p17 subunit of active caspase 3 generated by cleavage of the pro-caspase 3 at Asp175. The PARP antibody (mouse monoclonal) detects only the apoptosis-specific 89 kDa PARP fragment (cleaved-PARP) generated from the full length PARP by active caspases. Since the primary antibodies used are both mouse and rabbit, a secondary antibodies cocktail of GAM-HRP and GAR-HRP is provided.

The Apoptosis western blot cocktail (ab136812) is designed to study the induction of apoptosis in response to various stimuli. The two main components of this cocktail are monoclonal antibodies specific to caspase 3 and PARP. Caspase 3 is one of the executioner caspases activated by proteolytic cleavage during apoptosis. The rabbit caspase 3 antibody of this cocktail detects both the 32 kDa pro-caspase 3 as well as the p17 subunit of the active caspase 3 generated by cleavage of the pro-caspase 3 at Asp175. Thus the induction of apoptosis can be followed by a decrease of the pro-caspase 3 or by an increase of the p17 caspase 3. Monitoring the changes in the pro-caspase 3 is particularly advantageous, since the proportion of caspase activation can be determined from the reduction of the pro-form from analysis of control and stimulated samples. Poly [ADP-ribose] polymerase 1 (PARP) is a DNA repair enzyme that is cleaved during apoptosis by activated caspases. The mouse PARP antibody of this cocktail detects only the apoptosis-specific 89 kDa PARP fragment (cleaved-PARP). This antibody does not react with the full-length PARP. Combined, these two antibodies provide biomarkers of apoptosis. The rabbit muscle actin antibody is provided as a loading control for sample to sample normalization. Since the primary antibodies are both mouse and rabbit, the cocktail of HRP-conjugated goat anti-rabbit and anti-mouse secondary antibodies is provided for convenience. The targets are easily resolved by Western blot given their different molecular weights.

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed : 18723680, PubMed : 20566630, PubMed : 23650375, PubMed : 35338844, PubMed : 35446120, PubMed : 7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed : 18723680, PubMed : 20566630, PubMed : 23650375, PubMed : 7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond (PubMed : 10497198, PubMed : 16374543, PubMed : 7596430, PubMed : 7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed : 7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed : 37993714, PubMed : 9334240). Involved in the cleavage of huntingtin (PubMed : 8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed : 21357690). Cleaves DSG2 in response to apoptosis resulting in a loss of full length DSG2 at desmosome cell junctions and subsequent loss of cell-cell adhesion (PubMed : 17559062). Also cleaves JUP in response to apoptosis (PubMed : 17559062). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed : 23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed : 30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed : 35338844, PubMed : 35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed : 23845944, PubMed : 33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed : 36758104, PubMed : 36758106).
See full target information CASP3

Additional targets

PARP1,ACTC1

Publications (51)

Recent publications for all applications. Explore the full list and refine your search

Annals of surgical treatment and research 108:374-389 PubMed40503265

2025

MicroRNA-18b regulates cell cycle progression in papillary thyroid carcinoma by targeting : an experimental study.

Applications

Unspecified application

Species

Unspecified reactive species

Ju-Yeon Kim,Jae-Myung Kim,Eun Jung Jung,Youngsim Son,Seung-Jin Kwag,Ji-Ho Park,Jin-Kyu Cho,Han-Gil Kim,Dong-Hwan Kim,Sang-Ho Jeong,Chi-Young Jeong,Young-Tae Ju,Young-Joon Lee

Nature communications 16:4274 PubMed40393984

2025

CREBBP inactivation sensitizes B cell acute lymphoblastic leukemia to ferroptotic cell death upon BCL2 inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Alicia Garcia-Gimenez,Jonathan E Ditcham,Dhoyazan M A Azazi,George Giotopoulos,Ryan Asby,Eshwar Meduri,Jaana Bagri,Nathalie Sakakini,Cecile K Lopez,Nisha Narayan,Tumas Beinortas,Shuchi Agrawal-Singh,Kent Fung,David O'Connor,Marc R Mansour,Husam B R Alabed,Benjamin Jenkins,Albert Koulman,Michael P Murphy,Sarah J Horton,Brian J P Huntly,Simon E Richardson

Journal of nanobiotechnology 23:249 PubMed40133959

2025

Radiation-induced ferroptosis via liposomal delivery of 7-Dehydrocholesterol.

Applications

Unspecified application

Species

Unspecified reactive species

Jianwen Li,Shuyue Zhan,Wei Yang,He Zhang,Xinrui Ma,Fanghui Chen,Amy Li,Pakteema Tong,Fangchao Jiang,Zhengwei Cao,Ian Delahunty,Jiayi Wang,Yufei Wu,Zhi Liu,Zibo Li,Yong Teng,Libin Xu,Jin Xie

Science translational medicine 17:eadn6274 PubMed39970230

2025

A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Veronica Rendo,Eudocia Q Lee,Connor Bossi,Nicholas Khuu,Michelle A Rudek,Sangita Pal,Narmen Azazmeh,Rumana Rashid,Jia-Ren Lin,Margaret Cusick,Abigail R N Reynolds,Auriole C R Fassinou,Georges Ayoub,Seth Malinowski,Emily Lapinskas,William Pisano,John Jeang,Sylwia A Stopka,Michael S Regan,Johan Spetz,Arati Desai,Frank Lieberman,Kamalakannan Palanichamy,Joy D Fisher,Kristine Pelton,Raymond Y Huang,Kristopher A Sarosiek,Louis B Nabors,Matthias Holdhoff,Neeraja Danda,Roy Strowd,Serena Desideri,Tobias Walbert,Xiaobu Ye,Arnab Chakravarti,Peter K Sorger,Sandro Santagata,Nathalie Y R Agar,Stuart A Grossman,Brian M Alexander,Patrick Y Wen,Keith L Ligon,Rameen Beroukhim

Genes & development 38:738-754 PubMed39168636

2024

The SAGA acetyltransferase module is required for the maintenance of MAF and MYC oncogenic gene expression programs in multiple myeloma.

Applications

Unspecified application

Species

Unspecified reactive species

Ying-Jiun C Chen,Govinal Badiger Bhaskara,Yue Lu,Kevin Lin,Sharon Y R Dent

Journal of medicinal chemistry 67:15411-15427 PubMed39159487

2024

Examining Hemin and its Derivatives: Induction of Heme-Oxygenase-1 Activity and Oxidative Stress in Breast Cancer Cells through Collaborative Experimental Analysis and Molecular Dynamics Simulations.

Applications

Unspecified application

Species

Unspecified reactive species

Amir M Alsharabasy,Panagiotis I Lagarias,Konstantinos D Papavasileiou,Antreas Afantitis,Pau Farràs,Sharon Glynn,Abhay Pandit

PloS one 19:e0299403 PubMed38489292

2024

The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion.

Applications

Unspecified application

Species

Unspecified reactive species

Patcharin Tepjanta,Kazuhito Fujiyama,Ryo Misaki,Ingorn Kimkong

Scientific reports 13:23038 PubMed38155155

2023

A simple and rapid assay of lysosomal-targeting CDy6 for long-term real-time viability assessments in 2D and 3D in vitro culture models.

Applications

Unspecified application

Species

Unspecified reactive species

Chanhan Kang,Won-Soo Yun,Yun-Mi Jeong

Antioxidants (Basel, Switzerland) 12: PubMed37507960

2023

Manoalide Induces Intrinsic Apoptosis by Oxidative Stress and Mitochondrial Dysfunction in Human Osteosarcoma Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi-Kang Yao,Yen-Hsuan Jean,Sung-Chun Lin,Yu-Cheng Lai,Nan-Fu Chen,Chung-Chih Tseng,Wu-Fu Chen,Zhi-Hong Wen,Hsiao-Mei Kuo

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 22:2037-2053 PubMed37166570

2023

The synthesis of novel water-soluble zinc (II) phthalocyanine based photosensitizers and exploring of photodynamic therapy activities on the PC3 cancer cell line.

Applications

Unspecified application

Species

Unspecified reactive species

Nagihan Kocaağa,Ayşegül Türkkol,Mehmet Dinçer Bilgin,Ali Erdoğmuş
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com